Northwestern Medicine, one of America’s premier, academic healthcare systems, is partnering with Founders Factory to bring the UK’s and Europe’s top AI founders to the US health market. This programme reflects Northwestern Medicine’s strategy to embrace innovations that advance new models of patient care, advance research and deliver operational efficiencies.
AI-enabled technologies are instrumental to improving healthcare. From detection and chronic disease management to treatment optimism, systems-wide change and expediting research, AI delivers far-reaching benefits across health systems.
Our programme offers founders $150k capital, 16 weeks support across product development, fundraising, GTM and commercialisation.
The programme includes a partner track to accelerate customer discovery, use case development and pilot execution with Northwestern Medicine in Chicago and the London Clinic in the UK. Northwestern Medicine is one of the premiere US health ecosystems: 11 hospitals, 5,400+ affiliated physicians, research facilities, 200+ outpatient/diagnostic sites and Northwestern Memorial Hospital.
As part of the programme,
founders will attend a Residency Week in Chicago to scope and secure pilots with Northwestern Medicine, engage with our partners in the wider US healthcare ecosystem, and connect with local investors. The programme will culminate with an investor showcase in London, giving founders the opportunity to find investors in both markets.